Cargando…
Device-related infection in a large tertiary center-Benefit of the antibacterial envelope
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Cardiac implantable electronic device (CIED) infection carry a high morbidity and mortality. According to current data, the risk for a device-related infection is in a range of 0.6-3.4 % due to the latest EHRA consensus practical g...
Autores principales: | Hofer, D, Avdi, D, Ruegg, P, Saguner, A M, Molitor, N, Breitenstein, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207573/ http://dx.doi.org/10.1093/europace/euad122.494 |
Ejemplares similares
-
Efficacy of antibacterial envelope use in cardiac implantable electronic device infection prevention: insights from real world data
por: Ziacchi, M, et al.
Publicado: (2023) -
Occlusion balloon during transvenous lead extraction-Lessons learned from a case series
por: Hofer, D, et al.
Publicado: (2023) -
Single center experience with a novel short rotating dilator sheath in transvenous lead extraction
por: Hofer, D, et al.
Publicado: (2023) -
Leadless pacemaker implantation following transvenous lead extraction: data from i-LEAPER registry
por: Mitacchione, G, et al.
Publicado: (2023) -
Incidental findings at FDG PET/CT in carriers of cardiovascular implantable electronic devices
por: Diemberger, I, et al.
Publicado: (2023)